Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
Author:
Affiliation:
1. Department of Medicine Division of Nephrology Transplant Immunotherapy Program Cedars‐Sinai Medical Center Los Angeles California USA
2. Hansa Biopharma Lund Sweden
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16828
Reference19 articles.
1. Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation
2. Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?
3. Beyond CPRA: Identifying Sensitized Kidney Candidates with Markedly Low Access to Deceased Donor Transplantation by Granular CPRA and Blood Type
4. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors
5. Desensitization in HLA-Incompatible Kidney Recipients and Survival
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Escherichia coli in the production of biopharmaceuticals;Biotechnology and Applied Biochemistry;2024-09-08
2. Roles of M1 and M2 macrophage infiltration in post-renal transplant antibody-mediated rejection;Transplant Immunology;2024-08
3. New Therapies for Highly Sensitized Patients on the Waiting List;Kidney360;2024-07-12
4. Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer;Molecular Therapy;2024-07
5. Imlifidase – ein innovativer Therapieansatz in der Nephrologie;Die Nephrologie;2024-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3